CAS 84629-61-8

Darenzepine

Description:

Darenzepine is a chemical compound primarily recognized for its potential use in the treatment of cognitive disorders, particularly Alzheimer's disease. It functions as a selective antagonist of certain subtypes of the muscarinic acetylcholine receptors, which are crucial for cognitive processes. Darenzepine is characterized by its ability to enhance cholinergic neurotransmission, thereby potentially improving memory and learning functions. The compound has a relatively low molecular weight and exhibits moderate lipophilicity, which may influence its bioavailability and distribution in the central nervous system. Additionally, Darenzepine has been studied for its neuroprotective properties, suggesting it may help mitigate neurodegeneration associated with various forms of dementia. Its pharmacological profile indicates a favorable safety margin, although further clinical studies are necessary to fully establish its efficacy and long-term effects. Overall, Darenzepine represents a promising avenue in the pharmacological management of cognitive decline, although its clinical application remains under investigation.

Darenzepine

CAS: 84629-61-8

Darenzepine

Purity: ≥98%

Molecular weight: 347.41g/mol

Ref: 54-BUP07030

Darenzepine

CAS: 84629-61-8

Darenzepine is a long-acting, injectable antipsychotic drug used to treat schizophrenia and other psychotic disorders. Darenzepine is administered by intramuscular injection for the treatment of schizophrenia in adults. It is also used for the treatment of acute mania. Darenzepine is an atypical antipsychotic drug that blocks dopamine receptors in the brain. It has been shown to be effective in treating schizophrenia, bipolar disorder, and acute mania. Darenzepine has been observed to be more effective than placebo in reducing psychotic symptoms in adults with schizophrenia, but does not seem to have any effect on cognitive function. In addition, darenzepine may reduce the risk of relapse in patients with chronic schizophrenia.

Formula: C₂₁H₂₁N₃O₂

Purity: Min. 95%

Molecular weight: 347.4 g/mol

Ref: 3D-JDA62961

Darenzepine

CAS: 84629-61-8

Darenzepine is a muscarinic receptor inhibitor.

Formula: C₂₁H₂₁N₃O₂

Purity: 99.87%

Color and Shape: Solid

Molecular weight: 347.41

Ref: TM-T10961